Premium
BioNexus Gene Lab Corporation (BGLC)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | 21.631 | 7.639 | -3.888 | -26.107 |
| Return on Equity (%) | 32.843 | 10.865 | -5.143 | -32.212 |
| Return on Invested Capital (%) | 34.512 | 12.291 | -5.697 | -39.103 |
| Operating Margin (%) | 11.176 | 7.902 | -2.663 | -26.538 |
| Net Profit Margin (%) | 9.605 | 5.627 | -3.257 | -26.906 |
| Book Value Per Share | 0.065 | 0.042 | 0.038 | 0.547 |
| Earnings Per Share | 0.011 | 0.004 | -0.002 | -0.149 |
| Cash Per Share | 0.007 | 0.003 | 0.004 | 0.149 |
| Working Capital Per Share | 0.045 | 0.028 | 0.023 | 0.363 |
| Operating Profit Per Share | 0.026 | 0.014 | 0.009 | 0.107 |
| EBIT Per Share | 0.012 | 0.006 | -0.002 | -0.148 |
| EBITDA Per Share | 0.012 | 0.006 | -0.002 | -0.148 |
| Free Cash Flow Per Share | 0.014 | 0.004 | -0.002 | -0.145 |
| Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
| Actions en circulation | N/A | N/A | 173,72M | 17,67M |
| Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
| Actions en circulation | 173,72M | 173,72M | 173,72M | N/A | 17,67M | 17,67M | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -2.146 | N/A | N/A | N/A | -3.317 | N/A | N/A |
| Net Profit Margin (%) | N/A | -2.903 | N/A | N/A | N/A | -4.366 | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 6,83M |
| Ratio cours/bénéfice | -2,6 |
| Ratio prix/ventes | 0,67 |
| Ratio prix/liquidités | 2,6 |
| Ratio prix/valeur comptable | 0,71 |
| Rendement de dividende | - |
| Actions en circulation | 17,97M |
| Volume moyen (1 semaine) | 128,69k |
| Volume moyen (1 mois) | 215,49k |
| Variation sur 52 semaines | -68,60% |
| Plus haut sur 52 semaines | 1,40 |
| Plus bas sur 52 semaines | 0,2105 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
